RET-IN-25 (compound 6b) is an anticancer RET kinase inhibitor effective against medullary thyroid carcinoma (MTC), with half-maximal inhibitory concentrations (IC50s) of 3.6 µM at 3 days and 3.0 µM at 6 days in TT(C634R) MTC [1].
Molecular Weight:
435.45
CAS Number:
[2965703-02-8]
Formula:
C22H17N3O5S
Target:
c-RET|||Others
T79726
* VAT and and shipping costs not included. Errors and price changes excepted
